In November 2021, Northwestern University researchers introduced an injectable new therapy, which harnessed fast-moving “dancing molecules,” to repair tissues and reverse paralysis after severe spinal cord injuries.
EC approves Pfizer’s Talzenna combo for prostate cancer treatment
Share this article The EC approval extends use of Pfizer’s Talzenna combo to all 27 member states in the EU plus Liechtenstein, Iceland and Norway.